• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Pandemic Control Practices Cut Health Care-Acquired Infections

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Oct. 18, 2023 -- Strict infection prevention and control (IPC) measures enacted during the COVID-19 pandemic led to a significant decrease in many hospital-associated infections (HAIs), according to a study published online Oct. 4 in the American Journal of Infection Control.

Rita Wilson Dib, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues evaluated the effect of enhanced IPC practices on the occurrence of various HAIs. The analysis included incidence rates (IRs) of HAIs for Clostridioides difficile infection, multidrug-resistant organisms, respiratory viral infections (RVIs), and device-related infections at a comprehensive cancer center (September 2016 through March 2022).

The researchers found that the IR across all multidrug-resistant organisms was similar. There was a decrease in the IR of central line-associated bloodstream infections and a stable IR of catheter-associated urinary tract infections. There was a significant decrease seen in the IR of C. difficile infection. There was a decrease in total IR of nosocomial RVIs, as well as for each respiratory virus. For COVID-19 community surge versus nonsurge periods, there was similar IR of nosocomial RVIs, except for severe acute respiratory syndrome coronavirus 2, respiratory syncytial virus, and influenza. Compared with non-COVID-19 wards, multidrug-resistant organisms were five times more likely to occur on the COVID-19 wards.

"The encouraging findings from this study suggest that prioritizing and investing in evidence-based IPC practices can reduce HAIs, even among particularly vulnerable populations during extreme situations such as the COVID-19 pandemic," Patricia Jackson, R.N., president of the Association for Professionals in Infection Control, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.